| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030621 Ginkgo biloba composition, method to prepare the same and uses thereof |
| 02/29/2000 | CA2169179C 5-arylindole derivatives |
| 02/24/2000 | WO2000009666A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |
| 02/24/2000 | WO2000009503A1 Integrin receptor antagonists |
| 02/24/2000 | WO2000009496A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 02/24/2000 | WO2000009491A1 Calcilytic compounds |
| 02/24/2000 | WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009165A1 Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 02/24/2000 | WO2000009153A1 Compositions and methods for treating lysosomal storage disease |
| 02/24/2000 | WO2000009149A1 Tnf-derived peptides for use in treating oedema |
| 02/24/2000 | WO2000009146A1 Treatment of disease states |
| 02/24/2000 | WO2000009132A1 Calcilytic compounds |
| 02/24/2000 | WO2000009123A1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 02/24/2000 | WO2000009122A1 Pharmaceutical compositions containing lipase inhibitors |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO2000000039B1 Process and product for promoting weight loss in overweight dogs |
| 02/24/2000 | WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 02/24/2000 | DE19836382A1 Neues Tiermodell zur Entstehung und Therapie von Diabetes Mellitus New animal model for the pathogenesis and therapy of diabetes mellitus |
| 02/24/2000 | DE19834610A1 New N-dipeptidyl O-acyl hydroxylamine derivatives useful as dipeptidyl peptidase I inhibitors, e.g. for treating cancer or immunological or metabolic disorders |
| 02/24/2000 | CA2740912A1 Carbohydrate mixtures |
| 02/24/2000 | CA2340341A1 Calcilytic compounds |
| 02/24/2000 | CA2340257A1 Treatment of disease states |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2340068A1 Calcilytic compounds |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2339326A1 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/24/2000 | CA2305768A1 Compositions and methods for treating lysosomal storage disease |
| 02/23/2000 | EP0980437A1 HMG-CoA REDUCTASE INHIBITOR PREPARATION PROCESS |
| 02/23/2000 | EP0980433A1 Uncoupling protein homologue: ucp 3 |
| 02/23/2000 | EP0980349A1 Conjugated linolenic acid-based synthetic triglycerides |
| 02/23/2000 | EP0980250A1 Plant extracts for the treatment of increase bone resorption |
| 02/23/2000 | EP0980241A1 Gelatine encapsulated solution dosage forms of sertraline |
| 02/23/2000 | EP0832063B1 Vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 02/23/2000 | EP0792268B1 Hypolipidemic benzothiazepines |
| 02/23/2000 | CN1245494A New 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 02/23/2000 | CN1245425A Poly(diallylamine)-based bile acid sequestrants |
| 02/23/2000 | CN1245161A Process for preparing chromium L-threonate, its preparing process and application |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/22/2000 | US6028207 A tetracycline type antibiotic covalent bonded with a steroid type hormone estrogen has an osteogenesis function in addition to a bone resorption inhibition, can concentrate on the bone tissues |
| 02/22/2000 | US6028197 Dibenzo[a,g]quinolizinium derivatives and the salts thereof |
| 02/22/2000 | US6028184 For transgenic cells; for diagnosis of hypoglycemia, psychological and brain disorders; antidiabetic/hyperglycemic agents |
| 02/22/2000 | US6027921 Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins |
| 02/22/2000 | CA2258095C Tetrahydrolipstatin containing compositions |
| 02/22/2000 | CA2023563C Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
| 02/21/2000 | CA2280596A1 New indan-1-ol derivatives, their preparation method, and pharmaceutical compositions containing them |
| 02/17/2000 | WO2000008013A2 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists |
| 02/17/2000 | WO2000008002A1 SUBSTITUTED OXAZOLES AND THIAZOLES DERIVATIVES AS hPPAR GAMMA AND hPPAR ALPHA ACTIVATORS |
| 02/17/2000 | WO2000007994A1 Novel bi- and tri-cyclic aza compounds and their uses |
| 02/17/2000 | WO2000007991A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/17/2000 | WO2000007986A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz[f]indoles, a method for the production thereof, and their use as medicaments |
| 02/17/2000 | WO2000007972A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | WO2000007624A2 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 02/17/2000 | WO2000007617A1 Use of glp-1 and analogues for preventing type ii diabetes |
| 02/17/2000 | WO2000007606A2 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
| 02/17/2000 | WO1999065942A8 Cyclic somatostatin analogs |
| 02/17/2000 | WO1999056763A9 Use of neglected target tissue antigens in modulation of immune responses |
| 02/17/2000 | DE19836697A1 New substituted 4-amino-2-aryl-pyrimidines, are soluble guanylate cyclase activators useful e.g. for treating atherosclerosis, hypertension, angina pectoris, thrombosis, asthma or diabetes |
| 02/17/2000 | CA2339773A1 Substituted oxazoles and thiazoles derivatives as hppar gamma and hppar alpha activators |
| 02/17/2000 | CA2339643A1 Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria |
| 02/17/2000 | CA2339194A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 02/17/2000 | CA2339122A1 Novel bi- and tri-cyclic aza compounds and their uses |
| 02/17/2000 | CA2338121A1 Amide derivatives useful as inhibitors of the production of cytokines |
| 02/16/2000 | EP0979872A1 Animal model for the development and therapy of diabetes mellitus |
| 02/16/2000 | EP0979653A1 Remedy for chronic fatigue syndrome |
| 02/16/2000 | EP0979311A1 $i(IN VIVO) USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979230A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| 02/16/2000 | EP0979228A1 Novel cannabinoid receptor agonists |
| 02/16/2000 | EP0979092A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 02/16/2000 | EP0979081A1 Composition and methods using an eutomer |
| 02/16/2000 | CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 02/16/2000 | CN1244801A Sulfonylurea-glitazone synergistic combinations for diabetes |
| 02/16/2000 | CN1244531A Momordicine extracting process |
| 02/16/2000 | CN1244528A Di- Or triaza-spiral [4,5] decane derivative |
| 02/16/2000 | CN1244397A Diabetes treating medicine |
| 02/16/2000 | CN1244360A Antilipemic beverage |
| 02/16/2000 | CN1049334C New use of fatty acid medicine |
| 02/15/2000 | USRE36575 Pyridine and thiazolidinedione derivatives |
| 02/15/2000 | US6025381 3,4-(diphenyl)chromans |
| 02/15/2000 | US6025378 Antiatherosclerotic action. |
| 02/15/2000 | US6025372 Somatostatin agonists |
| 02/15/2000 | US6025332 Method for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3 |
| 02/15/2000 | US6025325 Pegylated obese (ob) protein compositions |
| 02/15/2000 | US6025198 Antisense modulation of Ship-2 expression |
| 02/15/2000 | US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same |
| 02/15/2000 | US6024960 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
| 02/15/2000 | CA2172855C Cholesterol or neutral fat level reducer |
| 02/15/2000 | CA2058398C 1,4 benzothiazine-2-acetic acid derivatives, processes for production thereof |
| 02/15/2000 | CA2006008C Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| 02/10/2000 | WO2000007014A2 Leptin-mediated gene-induction |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006712A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | WO2000006601A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006558A1 Antidiabetic piperazine derivatives, processes for their preparation and compositions containing them |